11111

Conferencistas

11111

Conferencistas

Conferencistas

Dr. Alejandro Videla

Jefe del servicio de Neumología, Hospital Universitario Austral, Argentina

Dr. Alfredo Guerreros

Director Médico Corporativo de la Clínica Internacional, Perú

Dr. Carlos Álvarez

Director UNICEF, Perú

Dr. Carlos del Río

Presidente de la Sociedad Estadounidense de Enfermedades Infecciosas

Dra. Catia Cilloniz

Profesora Asociada, Universidad de Barcelona, España.

Dr. Charles Dela Cruz

Profesor Asociado de Medicina, Colegio de Medicina de Yale, EE.UU

Dr. Cesar Munayco Escate

Director General del Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Perú

Dr. Chris Murray

Director del Instituto de Evaluación y Métrica de la Salud (IHME), EE.UU

Dr. Claudio Lanata

Director del Instituto de Evaluación y Métrica de la Salud (IHME), EE.UU

Dra. Gail Rodgers

Director Adjunto Departamento Neumología, Bill and Melinda Gates Foundation

Dra. Gisela Robles

Investigador de la carga global de enfermedades, El Centro de Medicina Tropical y Salud Global, Reino Unido

Dr. Jarbas Barbosa

Director de la Organización Panamericana de la Salud

Dra. Juana del Valle

Docente Investigador, Universidad Peruana de Ciencias Aplicadas-UPC, Perú

Eng. Lucio Flavio de Magalhaes Brito

Comisionado de Oxígeno para la Salud Global de Lancet, Brasil

Dr. Murat Ozturk

Asesor Principal, Fondo Rotatorio para el Acceso a Vacunas, OPS, EE.UU

Dra. Patricia J. García

Miembro, Instituto de Medicina de las Academias Nacionales, Perú

Dra. Maria Patricia Rivera

Presidente de la Sociedad Torácica Americana (ATS)

Dra. Pilar Collantes

Presidente de Voces Ciudadanas, Perú

Dr. Roberto Accinelli

Director of Height Research Institute, Peru

Dra. Romina Libster

Director de la Red de Ensayos de Vacunas, Investigación de vacunas y virus respiratorios, USA

Dr. Walter Curioso

Vicerrector de Investigación, Universidad Continental, Perú.

Dr. William Checkley

Profesor Asociado, Johns Hopkins Bloomberg School of Public Health, EE.UU

Dr. Yasir Bin Nisar

Médico, OMS

Carina King, MD

Karolinska Institute, Department for Global Public Health, Solna, Sweden

Dimitris Kontopidis, MD

President, European Lung Foundation (ELF)

Fiona Russell, PROF

Department of Paediatrics, The University of Melbourne, Melbourne, VIC 3052, Australia; Infection and Immunity, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Francisco Arancibia, PROF

Past- President, The Latin American Thoracic Association (ALAT)

Heather Zar, PROF

Department of Pediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa.

Julio Tejada, MD

President of the College of Physicians and Surgeons of Guatemala

Karen Czischke, MD

Department of Pulmonary Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile

Kevin Baker, MD

International Consultan

Kjeld Hansen, MR

Representative of The European Lung Foundation

Noni Macdonald, PROF

Division of Infectious Diseases, Department of Paediatrics, Dalhousie University and IWK Health Centre, Halifax, NS

Refiloe Masekela, PROF

President, Pan African Thoracic Society (PATS)

Zoë Mullan, MD

Editor-in-Chief, The Lancet Global Health

Add Your Heading Text Here

Add Your Heading Text Here

Add Your Heading Text Here

Add Your Heading Text Here

Dear Colleagues & Friends,

As Chairpersons of the 4th Global Conference for World Pneumonia Day 2024, it gives us great pleasure to invite you to join our event, which is part of the Worldwide Pneumonia Awareness Campaign-Pneumolight, with the support of the Philippine College of Physicians (PCP) in Manila, to be held on 9 November 2024.

Despite the global impact of the COVID-19 pandemic, pneumonia remains a neglected disease. Sadly, the 2021 Global Burden of Disease report showed that 2.1 million people died of pneumonia in that year; children under five years and adults over 70 continued to be the most vulnerable populations, with more than 500,000 and 1 million pneumonia-related deaths respectively. Another important problem is the impact of antimicrobial resistance (AMR); according to the 2019 GBD report, 1.27 million deaths were attributable to bacterial AMR in that year, and one in five deaths caused by AMR occurred in children under five years old. The 2019 GBD report identified Streptococcus pneumoniae as the most frequent pathogen causing pneumonia,
contributing to 16% of the deaths attributable to AMR.

Although great progress continues to be made, the worldwide burden of pneumonia remains huge. We need everyone to know about the disease and its impact on our health, and above all, we need to show that it can be prevented. Pneumonia must be recognized as a major global health problem. Until this recognition comes, we will continue our attempts to educate and prevent, because we know that education is prevention and prevention saves lives.

Working together, we can move the world because we know that if we fight, we can win!!!!

Yours sincerely,

Catia Cilloniz
Guinevere Dy-Agra
Rodolfo S. Pagcatipunan Jr

Esto se cerrará en 0 segundos

Esto se cerrará en 0 segundos

Esto se cerrará en 0 segundos

Louis Bont, MD, PhD


Louis Bont, MD, PhD, is a Pediatric Infectiologist-Immunologist and the head of the Pediatric Department at the University Medical Center Utrecht, The Netherlands. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interests include RSV pathogenesis and the burden of disease.

Dr. Bont's work focuses on unraveling the role of neutrophils, RSV-related mortality, and long-term airway disease following RSV infection. He is the lead investigator of the INFORM study, a large prospective global clinical virology study that aims to uncover the molecular epidemiology of RSV in over 2000 children. He also leads the RSV GOLD mortality registry, funded by the Bill and Melinda Gates Foundation.

His group collaborates with the World Health Organization on RSV surveillance and vaccine development. Dr. Bont’s research emphasizes clinical and translational mechanisms of disease and the identification of intervention targets for RSV bronchiolitis. He has been the lead author of over 300 publications in peer-reviewed medical journals.

Additionally, he founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a career training network for clinician scientists in the field of Child Health.

Esto se cerrará en 0 segundos

Esto se cerrará en 0 segundos